Background: Poor knowledge, attitude and self-care practices (KAP) as regards medication compliance is a major concern in the management of glaucoma. This study aims to evaluate the knowledge, attitude regarding eyedrop instillation and selfcare practices pertaining to eyedrops in diagnosed glaucoma patients.
InTRoDuCTIon
Glaucoma is the leading cause of irreversible blindness worldwide. 1, 2 It is a group of ocular disorders with multifactorial etiology united by a clinically characteristic intra ocular pressure-associated optic neuropathy and corresponding visual field defects and is said to be the third leading cause of blindness in India. When glaucoma is diagnosed, whether in the presence of normal or elevated IOP, it needs to be treated. Across the globe, topical medications are typically the first-line therapy, followed by laser and/or surgical therapy. Eyedrops have been used in ophthalmology since ages. Despite many advances in management of ophthalmic diseases, ophthalmologists have not been able to find a way that obviates the eyedrop usage. Multiple clinical trials have shown that with effective medical treatment, vision loss can be prevented. [3] [4] [5] Adherence, persistence and correct administration are three key elements for a successful topical pharmaco therapy for glaucoma patients. Because topically applied medications are the mainstay of glaucoma therapy, patients and family physicians need to be familiar with their stated purpose and their place in glaucoma therapy. As physicians, we all are aware that many of our patients do not use ocular hypotensives in the manner prescribed. Nonadherence in patients with glaucoma ranges from 5 to 80%. 6, 7 Reasons for this poor compliance are multi-
factorial.
This simple open ended questionnaire-based pilot study aimed to check for the evaluation of the techniques being used by the patients for eyedrop instillations which can affect their drug compliance.
MATeRIAlS AnD MeTHoDS
All the patients were thoroughly examined before inclu sion in the study. The basic demographic details of each patient were recorded along with the type of glaucoma, name, number and duration of medications being instilled. All subjects were consented prior to enrolment and the protocol followed the tenets of the declaration of Helsinki. The KAP survey consisted of 10 questions and the main aim was to assess patients' awareness and knowledge as regards the eyedrops. Data were analyzed using the SPSS version 21.00 (Chicago, Illinois, USA).
• 
Knowledge
Nearly all patients, 99 (98%) knew the reason why they were instilling eyedrops. The proportion of people who expressed that, the eyedrops should be stored in cool and wet place was only 4%. Sixty two (61.4%) subjects said that the eyedrops should be stored in cool and dry place and the remaining 35 (34.6%) said the eyedrops should be stored in a warm place.
Twenty eight (27.7%) participants said that, two eye drops can be instilled back to back. One participant did not know about it and the remaining 72 (71.3%) knew that two eyedrops cannot be instilled back-to-back.
Attitude
Fifty six (55.4%) of the participants believed that it mattered to miss a dose of medicine. Majority (89.1%) of the participants usually asked their doctor about the drug dosage and timings. Nearly 70% (71) of them did not use the eyedrops 40 days after opening the vial. Thirty eight (37.6%) of them thought that they could discontinue the medicine without asking the doctor, once the symptoms were relieved.
Practice
Out of total 101 participants, 82 (81.2%) reported that, they check the vial for correct drug name and expiry date before buying. Fifty eight (57.4%) of the participants reported, they wash the hands before instilling eyedrops, 41 (40.6%) did not wash hands before instilling eyedrops and 2 (2%) people washed hands only sometimes. Twenty four (23.8%) people reported that, they ask their doctor for alternate medication name, in case they do not get the primary medication.
For each desirable answer the participant gave, a score of 1 was given and for each undesirable answer a score of '0' was given for each question. The total scores for each domain were calculated separately along with the total score. The association between the individual domain scores, the total score and various sociodemographic para meters were compared using unpaired t-test. ANOVA test was used to compare the means, where the exposure variable had more than 2 categories.
There were no statistically significant differences in the mean domain and total scores between males and females ( Table 1 ).
The residing area had no influence on the knowledge, attitude and practice scores, as there were no statistically significant differences between rural and urban popu lation in the individual domain scores and the total score (Table 2) .
There were very minor differences in knowledge scores in people with different educational qualification. These differences were statistically not significant (p-value 0.059) ( Table 3) . There were no statistically significant differences in knowledge (p = 0.059) and attitude (p = 0.809) scores in people with different educational qualification. But education had a statistically significant relation with the practice scores (p = 0.004) and total scores (p = 0.047) ( Table 3) .
DISCuSSIon
The study group was heterogeneous in nature representing various sections of the community.
There can be little doubt that noncompliance, poor adhe rence and persistence with the prescribed topical medical management for glaucoma account for treatment failure. This study focuses on the same through a simple KAP survey. The current pilot study aims to address the insufficiency of data in the literature pertaining to many of the practical aspects of eyedrop administration. Although, most participants in this study reported little difficulty with the use, storage, and handling of eyedrops, the survey results demonstrate that broad variations in reported practices appear to exist.
Many commercial eyedrop preparations come with a broad range of storage requirements. Many drugs lose their effectiveness if stored in hot, moist, or brightly illuminated places. Heat, moisture, and light trigger irrever sible physical changes to some of the chemical com pounds in these prescription drugs.
Most drugs specify an upper range for temperature expo sure during storage, 25ºC (77ºF), this temperature may easily exceed in areas such as the kitchen or bathroom or over the top of a refrigerator. Even the bedroom can have higher than these temperatures in warm climates without constantly maintained air conditioning. Some medications do not recommend storage temperatures in the near-freezing or refrigeration range. This may be especially problematic for the 4% who store medications in the refrigerator baffle tray, if instructions are not well under stood or if the temperature in the refrigerator is not held constant.
Nearly 30% patients believed that two drops could be instilled back-to-back. Patients need to be aware of the 'wash out effect' due to back-to-back instillation of drugs. This may be because eyecare practitioners often prescribe eyedrops without properly explaining or showing the technique for correct instillation of eyedrops. This may occur because of the paucity of time in busy practice or lack of awareness of the fact that the patient may not be able to put the eyedrop correctly.
JOCGP
Approximately, 56% of the participants claimed to never miss a dose; these results are consistent with those of Stone et al, 8 who in their study observed that 61% of the patients never missed a dose. Not missing a dose is an extre mely important parameter for checking adhe rence to anti glaucoma instillations and is related with worsening of the disease. In our study, 45 patients felt that missing a dose would not matter much. If patients missed a dose that implies that their drug vial lasts for more than 40 days. In addition, 26 (25.75%) patients used their drug vials beyond 40 days. Inappropriate dosing, because of either poor adherence or poor technique of instillation, means that patients are not receiving the prescribed medication as needed.
Thirty eight (37.6%) patients believed that if they got relieved of the symptoms, then the glaucoma medication could be discontinued without a follow-up visit with their doctor. This false belief can be detrimental to their disease status. This point should be addressed by each doctor while explaining the treatment to a glaucoma patient.
About 20% patients did not check the eyedrop vial for the correct drug name and expiry date before buying.
Nearly 75% did not ask for an alternative medication name from their doctor, in case the primary medication was not available. The possibility of a chemist substituting the prescribed drug for a wrong one cannot be ruled out. Hence, patients must ask for an alternative brand name for the prescribed drug from their doctor.
In our study, 58% of the participants reported washing of hands which was similar to the study done by Stone et al 8 who reported that 61.9% subjects routinely washed their hands before instilling eyedrops. This was also consistent with a report from Tsai et al 9 of 65% patients following the clean hands practice. These results need to be interpreted with great caution. Firstly this is a pilot study and it mainly depends upon the patients' self-report. Patients are known to over estimate their ability to comply with therapy. 10, 11 Secondly, enrolment in this study was limited to patients in glaucoma practices in either Chandigarh, Panchkula, Mohali and some parts of Punjab and Haryana. Greater geographical variation may yield varied outcomes. Furthermore, results may not be applicable to all forms of prescription or nonprescription eyedrop medications or to the therapies not specializing in glaucoma. Participants were asked about their use of antiglaucoma instillations only. Still, the results of this survey add to a growing body of literature that addresses many of the problems contributing to noncompliance with topical glaucoma therapy.
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ConCluSIon
The aim of this study was to ascertain the knowledge, atti tude and practices followed by patients suffering from a chronic disease, such as glaucoma, which requires almost life-long topical medication therapy. An attempt was made to question about even the minute details associated with the use, storage and handling of eyedrops. This study demonstrates that a broad variation exists in the reported practices, even in the very basic pre requisites of instilling eyedrops like washing of hands, checking the expiry date before the usage of eyedrops (which has been over looked by many of the studies avai lable in literature).
The findings in our study suggest a need to better educate our patients by providing them detailed infor mation about eyedrop and its administration and also highlight many of the methodological problems. This would help to reduce patients' frustration, improve compliance, and increase the efficacy of antiglaucoma therapy.
